Screener
Harmony Biosciences Holdings, Inc. HRMY Q4 2025 Annual earnings
Reported February 24, 2026 · Before market open
Revenue$243.8MBeat by $3.5M
EPS$0.38Miss by $0.46
Revenue estimate$240.3M
EPS estimate$0.84
Next report
Nov 3, 2026 (in 2 months)Revenue estimate$274.5M
EPS estimate$1.11
Segments
By segment
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Harmony Biosciences Holdings, Inc. report Q4 2025 earnings?
- Harmony Biosciences Holdings, Inc. (HRMY) reported Q4 2025 earnings on February 24, 2026 before market open.
- What were Harmony Biosciences Holdings, Inc.'s Q4 2025 revenue and EPS?
- Harmony Biosciences Holdings, Inc. reported revenue of $243.8M and eps of $0.38 for Q4 2025.
- Did Harmony Biosciences Holdings, Inc. beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $240.3M by $3.5M. EPS missed the consensus estimate of $0.84 by $0.46.
- How did Harmony Biosciences Holdings, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 21.1% from $201.3M a year earlier and eps declined 55.3% from $0.85.
- Where can I find Harmony Biosciences Holdings, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-26-018858) and the 10-K periodic report (0001104659-26-018859) directly on SEC EDGAR. The filing index links above go to sec.gov.
